市場調查報告書
商品編碼
1368389
全球細胞培養基、血清和試劑市場 - 預測(截至 2030 年)Global Cell Culture Media Market Research Report - Forecast to 2030 |
到 2030 年,全球細胞培養基、血清和試劑市場預計將達到 188 億美元,複合年增長率為 10.5%。 生物製藥的日益普及、慢性病病例的增加以及對細胞培養技術治療的興趣日益濃厚預計將推動市場發展。
區域分析
美洲市場規模最大。
歐洲預計將成為第二大市場,其次是亞太地區。 亞太地區是成長最快的市場。
本報告針對全球細胞培養基、血清和試劑市場進行研究和分析,提供市場動態、區域和細分市場分析、公司簡介等。
The media sera and reagents- cell culture market is projected to reach USD 18,800 Million by 2030 at 10.5% CAGR during the review period.
Cell culture is the way cells develop under controlled conditions outside the common habitat. In cell culture, the states of every cell type are unique, yet the fake climate comprises of a medium or reagents that give supplements to the cell.
The ascent of popularity for biotechnological and biopharmaceutical items, developing instances of expanding persistent illnesses, and the developing interest for treating utilizing cell culture techniques will drive the market's development. The higher interests in innovative work in biotechnology will emphatically impel the market's development. Numerous advancements in the field of rDNA innovation and drugs will animate the market's development. The capital venture for a Cell culture office is costly, which might obstruct the development of the market.
America possesses the biggest market because of extraordinary interest in innovative work in the biotech and pharma enterprises. The monetary circumstances for innovative work are considerably higher. The developing mindfulness among individuals and the presence of central members in this region will add to the development of the market.
Based on application, type, and end-user, the global media sera and reagents-cell culture market is divided into segments. The type segment is further divided into medium, sera, and reagents.
The media segment includes chemically defined media, serum-free media, protein-free media, traditional media, and others. The market based on sera is classified into fetal bovine serum, newborn calf serum, and various types of serum.
In terms of reagents the global sera, media, and cell culture market is further divided into antibiotics, biological detergents, biological buffers, cell viability kits and reagents, and others.
In terms of application, the global market is categorized into drug development, cancer research, toxicity testing, virology, vaccine development, and others based on applications.
The market is divided into pathology labs, academic institutions, research laboratories, and others by end users.
Regional analysis
America dominates the biggest market because of its immense interest in innovative work in biotech and pharma ventures and its monetary circumstances for innovative work. Rising mindfulness among individuals and the presence of many central members in this region have likewise contributed to the development of the market.
Europe is expected to become the second largest market for media sera and reagents-cell culture market followed by Asia Pacific. Because of the accessibility of assets for innovative work exercises and developing accentuation on research for treating sicknesses. Asia Pacific shows the quickest development in this market because of an expansion in commonness of transferable illnesses. For the most part, India and China are beginning use in innovative work areas of medical care space.
Key players
The major players in the media, sera and reagents-cell culture market are PAN biotech (Germany), Hi-media Laboratories (India), Sigma Aldrich (US), Thermofisher Scientific (US), Merck KGaA (Germany), Biowest (France), General Electric company (US), VWR International, Lonza AG (Switzerland), PromoCell GmbH, and others.
TABLE OF CONTENTS